Axonics (AXNX) News Today → Don’t buy a single NVIDIA share before you see this... (From Behind the Markets) (Ad) Free AXNX Stock Alerts $67.09 -0.04 (-0.06%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 4:55 AM | marketbeat.comNorges Bank Invests $37.65 Million in Axonics, Inc. (NASDAQ:AXNX)Norges Bank acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 604,931 shares of the company's stock, valued at approximately $37,645,000. Norges Bank ownedMay 29 at 9:37 AM | marketbeat.comArtisan Partners Limited Partnership Increases Stake in Axonics, Inc. (NASDAQ:AXNX)Artisan Partners Limited Partnership lifted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 91.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,220,889 shares of the company's stock after purchasing an additional 58May 28, 2024 | marketbeat.comDimensional Fund Advisors LP Purchases 56,418 Shares of Axonics, Inc. (NASDAQ:AXNX)Dimensional Fund Advisors LP raised its position in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 922,295 shares of the company's stock after purchasing an additional 56,May 24, 2024 | marketbeat.comBNP Paribas Financial Markets Reduces Position in Axonics, Inc. (NASDAQ:AXNX)BNP Paribas Financial Markets reduced its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 34.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,957 shares of the company's stock after sellMay 24, 2024 | americanbankingnews.comAxonics, Inc. (NASDAQ:AXNX) Given Average Recommendation of "Hold" by BrokeragesMay 24, 2024 | marketbeat.comAxonics, Inc. (NASDAQ:AXNX) Receives Average Recommendation of "Hold" from BrokeragesAxonics, Inc. (NASDAQ:AXNX - Get Free Report) has been assigned a consensus rating of "Hold" from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating toMay 18, 2024 | marketbeat.comInternational Assets Investment Management LLC Invests $817,000 in Axonics, Inc. (NASDAQ:AXNX)International Assets Investment Management LLC acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 13,131 shares of the company's stock, valued at approximateMay 17, 2024 | marketbeat.comSwiss National Bank Has $6.19 Million Holdings in Axonics, Inc. (NASDAQ:AXNX)Swiss National Bank lessened its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 10.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 99,400 shares of the company's stock after sellMay 16, 2024 | marketwatch.comAxonics Gets Australian Approval for Neurostimulator SystemMay 16, 2024 | businesswire.comAxonics Receives Regulatory Approval for Recharge-Free SNM System in AustraliaMay 14, 2024 | marketbeat.comAxonics, Inc. (NASDAQ:AXNX) Short Interest UpdateAxonics, Inc. (NASDAQ:AXNX - Get Free Report) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 3,410,000 shares, a decrease of 15.6% from the April 15th total of 4,040,000 shares. Based on an average daily volume of 826,100 shares, the short-interest ratio is presently 4.1 days.May 10, 2024 | marketbeat.comRussell Investments Group Ltd. Has $5.70 Million Holdings in Axonics, Inc. (NASDAQ:AXNX)Russell Investments Group Ltd. lifted its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 1,144,500.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 91,568 shares of the company's stock aMay 6, 2024 | marketbeat.comLisanti Capital Growth LLC Boosts Stock Holdings in Axonics, Inc. (NASDAQ:AXNX)Lisanti Capital Growth LLC lifted its holdings in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 41.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,950 shares of the company's stock afteMay 6, 2024 | marketbeat.comAxonics (NASDAQ:AXNX) Rating Reiterated by Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Axonics in a report on Monday.May 3, 2024 | marketbeat.comBoston Scientific Bucks the Medtech Slow Down and Raises Outlook (AXNX)Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.May 2, 2024 | marketbeat.comNew York State Common Retirement Fund Buys 34,989 Shares of Axonics, Inc. (NASDAQ:AXNX)New York State Common Retirement Fund boosted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 28.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 158,657 shares of the company's stock after purchasiMay 1, 2024 | markets.businessinsider.comWhat 23 Analyst Ratings Have To Say About Eli Lilly and CoMay 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Axonics Modulation Technologies (AXNX) and Eli Lilly & Co (LLY)May 1, 2024 | marketbeat.comAxonics (NASDAQ:AXNX) Announces Quarterly Earnings Results, Misses Expectations By $0.32 EPSAxonics (NASDAQ:AXNX - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.32). Axonics had a negative return on equity of 1.00% and a negative net margin of 1.66%. The business had revenue of $91.41 million during the quarter, compared to analysts' expectations of $89.79 million. During the same quarter in the prior year, the firm earned ($0.19) earnings per share. Axonics's quarterly revenue was up 29.4% on a year-over-year basis.April 30, 2024 | investorplace.comAXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024April 30, 2024 | businesswire.comAxonics Reports First Quarter 2024 Financial ResultsApril 28, 2024 | marketbeat.comAxonics, Inc. (NASDAQ:AXNX) Sees Significant Growth in Short InterestAxonics, Inc. (NASDAQ:AXNX - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 4,040,000 shares, a growth of 17.4% from the March 31st total of 3,440,000 shares. Based on an average trading volume of 919,900 shares, the short-interest ratio is presently 4.4 days.April 26, 2024 | marketbeat.comAxonics, Inc. (NASDAQ:AXNX) Stake Raised by Jennison Associates LLCJennison Associates LLC boosted its holdings in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 56.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 354,331 shares of the company's stock after acquiring an adApril 24, 2024 | prnewswire.comBoston Scientific Announces Results for First Quarter 2024April 24, 2024 | marketbeat.comInternational Assets Investment Management LLC Acquires Shares of 13,131 Axonics, Inc. (NASDAQ:AXNX)International Assets Investment Management LLC acquired a new stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 13,131 shares of the company's stock, valued at approximApril 21, 2024 | marketbeat.comCalamos Advisors LLC Takes Position in Axonics, Inc. (NASDAQ:AXNX)Calamos Advisors LLC acquired a new stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 60,694 shares of the company's stock, valued at approximately $3,7April 14, 2024 | marketbeat.comShort Interest in Axonics, Inc. (NASDAQ:AXNX) Increases By 17.0%Axonics, Inc. (NASDAQ:AXNX - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 3,440,000 shares, a growth of 17.0% from the March 15th total of 2,940,000 shares. Based on an average daily volume of 1,390,000 shares, the days-to-cover ratio is presently 2.5 days.April 10, 2024 | marketbeat.comImpax Asset Management Group plc Has $15.22 Million Holdings in Axonics, Inc. (NASDAQ:AXNX)Impax Asset Management Group plc lifted its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 244,525 shares of the company's stock afteApril 9, 2024 | marketbeat.comPeregrine Capital Management LLC Trims Holdings in Axonics, Inc. (NASDAQ:AXNX)Peregrine Capital Management LLC cut its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 14.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 169,629 shares of theApril 4, 2024 | marketbeat.comAxonics (NASDAQ:AXNX) Shares Gap Down to $69.65Axonics (NASDAQ:AXNX) Shares Gap Down to $69.65April 4, 2024 | reuters.comFTC seeks more information on Boston Scientific's $3.7 bln Axonics dealApril 4, 2024 | marketbeat.comAxonics, Inc. (NASDAQ:AXNX) Given Average Recommendation of "Hold" by AnalystsShares of Axonics, Inc. (NASDAQ:AXNX - Get Free Report) have earned an average rating of "Hold" from the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and five have assigned a buy recommendatMarch 29, 2024 | marketbeat.comFY2024 EPS Estimates for Axonics, Inc. (NASDAQ:AXNX) Lifted by AnalystAxonics, Inc. (NASDAQ:AXNX - Free Report) - Investment analysts at Leerink Partnrs upped their FY2024 earnings per share (EPS) estimates for shares of Axonics in a report released on Thursday, March 28th. Leerink Partnrs analyst M. Kratky now forecasts that the company will post earnings of $0.36March 28, 2024 | marketbeat.comVanguard Group Inc. Sells 72,029 Shares of Axonics, Inc. (NASDAQ:AXNX)Vanguard Group Inc. cut its position in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 1.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,262,314 shares of the company's stock after selling 72,029 shares duringMarch 26, 2024 | marketbeat.comOak Ridge Investments LLC Buys 47,252 Shares of Axonics, Inc. (NASDAQ:AXNX)Oak Ridge Investments LLC boosted its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 91.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,723 shares of thMarch 22, 2024 | businesswire.comAxonics Stockholders Approve Merger Agreement with Boston ScientificMarch 21, 2024 | businesswire.comAxonics Provides Update on Inter Partes Review ProceedingsMarch 20, 2024 | marketbeat.comAxonics, Inc. (NASDAQ:AXNX) Shares Sold by Ziegler Capital Management LLCZiegler Capital Management LLC lowered its position in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 63.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 61,292 shares of the company's stock after selling 104,848 shares during the period. ZMarch 18, 2024 | marketbeat.comShort Interest in Axonics, Inc. (NASDAQ:AXNX) Grows By 6.4%Axonics, Inc. (NASDAQ:AXNX - Get Free Report) saw a significant growth in short interest during the month of February. As of February 29th, there was short interest totalling 2,820,000 shares, a growth of 6.4% from the February 14th total of 2,650,000 shares. Based on an average trading volume of 1,220,000 shares, the days-to-cover ratio is presently 2.3 days.March 14, 2024 | businesswire.comAxonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemMarch 7, 2024 | marketbeat.comNorthern Trust Corp Sells 45,578 Shares of Axonics, Inc. (NASDAQ:AXNX)Northern Trust Corp lowered its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 6.9% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 611,149 shares of the company's stock after selling 45,578 shares during the period. Northern Trust Corp owMarch 6, 2024 | marketbeat.comRTW Investments LP Trims Stock Holdings in Axonics, Inc. (NASDAQ:AXNX)RTW Investments LP lowered its stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 50.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 442,487 shares of the company's stMarch 5, 2024 | marketbeat.comAxonics, Inc. (NASDAQ:AXNX) Shares Acquired by Sectoral Asset Management Inc.Sectoral Asset Management Inc. increased its stake in Axonics, Inc. (NASDAQ:AXNX - Free Report) by 35.2% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 172,950 shares of the company's stock after acquiring an additional 45March 1, 2024 | finance.yahoo.comAxonics Full Year 2023 Earnings: EPS Beats ExpectationsMarch 1, 2024 | marketbeat.comBraidwell LP Sells 219,264 Shares of Axonics, Inc. (NASDAQ:AXNX)Braidwell LP trimmed its holdings in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) by 38.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 354,527 shares of the company's stock after selling 219,264 shFebruary 29, 2024 | marketwatch.comAxonics Pushes Back Against Patent Dispute Alleged by MedtronicFebruary 29, 2024 | businesswire.comAxonics Responds to ITC Action by MedtronicFebruary 29, 2024 | markets.businessinsider.comBeyond The Numbers: 7 Analysts Discuss Axonics StockFebruary 28, 2024 | finance.yahoo.comAxonics Inc (AXNX) Reports Robust Revenue Growth and Margin Expansion in Q4 and FY 2023February 28, 2024 | marketbeat.comAlgert Global LLC Invests $1.31 Million in Axonics, Inc. (NASDAQ:AXNX)Algert Global LLC bought a new stake in shares of Axonics, Inc. (NASDAQ:AXNX - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 23,400 shares of the company's stock, valued at approximately $1,313,000. Several othe Get Axonics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXNX and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… AXNX Media Mentions By Week AXNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXNX News Sentiment▼1.190.79▲Average Medical News Sentiment AXNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXNX Articles This Week▼53▲AXNX Articles Average Week Get Axonics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LUNG News Today INO News Today SWAV News Today PODD News Today SOLV News Today TFX News Today GMED News Today PEN News Today GKOS News Today MMSI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXNX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axonics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
